News

Clinical Lab Products
clpmag. com > diagnostic-technologies > molecular-diagnostics > fda-breakthrough-blood-test-schizophrenia-bipolar-disorder

FDA Grants Breakthrough Status to Blood Test to Distinguish Schizophrenia and Bipolar Disorder

2+ hour, 29+ min ago  (214+ words) Apr 28, 2026 | Company News, Diagnostic Technologies, Molecular Diagnostics | The US Food and Drug Administration (FDA) granted Breakthrough Device Designation to an m RNA gene biomarker test from Laguna Diagnostics designed to aid in differentiating schizophrenia and bipolar I disorder in symptomatic…...